Effects of Etomidate on Postintubation Hypotension, Inflammatory Markers, and Mortality in Critically Ill Patients with COVID-19: An International, Multicenter, Retrospective Study.
Konstantinos LeouDianelys MendezGeorge HoraniNikolaos PapagiannakisRoberto Jiménez SánchezDiana MazzeiIsabel MoraRajapriya ManickamKonstantinos TourlakopoulosJosé Francisco Garrido PeñalverDavid Jiménez MedinaMaría Dolores Rodríguez MuleroKonstantinos AnnousisEleni LaouLuis García de Guadiana-RomualdoIoannis PantazopoulosKunwar KaurAthanasios Chalkiasnull nullPublished in: Journal of intensive care medicine (2023)
Administration of a single-bolus dose of etomidate in critically ill patients with COVID-19 is associated with lower postintubation mean arterial pressure and higher in-hospital and 30-day mortality compared to other induction agents.